Equities

Instituto de Diagnostico SA

INDISA:SGO

Instituto de Diagnostico SA

Actions
Health CareHealth Care Providers
  • Price (CLP)1,550.00
  • Today's Change24.80 / 1.63%
  • Shares traded1.53m
  • 1 Year change+11.48%
  • Beta0.6459
Data delayed at least 20 minutes, as of Nov 08 2024 16:05 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of CLP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income------
Depreciation/depletion------
Non-Cash items------
Cash taxes paid, supplemental114705(1567)
Cash interest paid, supplemental------
Changes in working capital(131184)(107663)(96422)
Total cash from operations21,03121,78314,832
INVESTING
Capital expenditures(8726)(24140)(33907)
Other investing and cash flow items, total3,4433,7021,189
Total cash from investing(5282)(20438)(32718)
FINANCING
Financing cash flow items(8609)(4891)(2888)
Total cash dividends paid(3918)(10316)(1748)
Issuance (retirement) of stock, net------
Issuance (retirement) of debt, net(4648)18,30017,208
Total cash from financing(17175)3,09312,573
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash(1426)4,438(5313)
Net cash-begin balance/reserved for future use14,1899,75115,065
Net cash-end balance/reserved for future use12,76314,1899,751
SUPPLEMENTAL INCOME
Depreciation, supplemental------
Cash interest paid, supplemental------
Cash taxes paid, supplemental114705(1567)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.